Vestal Point Capital, LP Portfolio Holdings

Vestal Point Capital, LP

  • $1.21 Trillion
  • Q1 2024

Vestal Point Capital, LP has filed its 13F form on May 13, 2024 for Q1 2024 where it was disclosed a total value porftolio of $1.21 Trillion distributed in 58 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Cytokinetics Inc with a value of $151B, Jazz Pharmaceuticals PLC with a value of $132B, Neurocrine Biosciences Inc with a value of $97.9B, Ascendis Pharma A/S with a value of $79.4B, and Globus Medical Inc with a value of $53.6B.

Examining the 13F form we can see an increase of $265B in the current position value, from $944B to 1.21T.

Vestal Point Capital, LP is based out at New York, NY

Below you can find more details about Vestal Point Capital, LP portfolio as well as his latest detailed transactions.

Portfolio value $1.21 Trillion
Healthcare: $1.11 Trillion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$5.1B
$151 Billion 12.47% of portfolio
2,150,000
Q1 2024 Added 4,200.0%
$6.69B
$132 Billion 10.95% of portfolio
1,100,000
Q1 2024 Added 51.72%
$13.2B
$97.9 Billion 8.1% of portfolio
710,000
Q1 2024 Reduced 11.25%
$7.61B
$79.4 Billion 6.56% of portfolio
525,000
Q1 2024 Reduced 16.0%
$5.28B
$53.6 Billion 4.44% of portfolio
1,000,000
Q1 2024 Added 25.0%
Soleno Therapeutics Inc
-
$53.5 Billion 4.42% of portfolio
-
Q1 2024 Reduced 3.85%
$29.9B
$52.3 Billion 4.33% of portfolio
350,000
Q1 2024 Added 900.0%
$14.8B
$50.8 Billion 4.2% of portfolio
325,000
Q1 2024 New
$2.57B
$38.4 Billion 3.17% of portfolio
800,000
Q1 2024 New
$224M
$34.7 Billion 2.87% of portfolio
5,110,000
Q1 2024 Added 22.98%
$772M
$29.5 Billion 2.44% of portfolio
2,000,000
Q1 2024 Added 95.12%
$246M
$29.1 Billion 2.41% of portfolio
2,610,000
Q1 2024 Added 57.7%
$242B
$27.1 Billion 2.24% of portfolio
400,000
Q1 2024 Added 60.0%
$209M
$24.6 Billion 2.03% of portfolio
4,725,000
Q1 2024 Added 20.38%
$9.08B
$20.3 Billion 1.68% of portfolio
750,000
Q1 2024 Reduced 16.67%
$23.8B
$19.7 Billion 1.63% of portfolio
50,000
Q1 2024 New
$2.58B
$16 Billion 1.32% of portfolio
1,050,000
Q1 2024 New
$138M
$15.5 Billion 1.28% of portfolio
1,100,000
Q1 2024 New
$15.3B
$15.3 Billion 1.26% of portfolio
175,000
Q1 2024 New
$0
$13.9 Billion 1.15% of portfolio
350,000
Q1 2024 New
Solid Biosciences Inc
-
$13.8 Billion 1.14% of portfolio
-
Q1 2024 Added 2,936.53%
Dianthus Therapeutics Inc
-
$13.7 Billion 1.13% of portfolio
-
Q1 2024 Added 237.04%
$4.21B
$13.2 Billion 1.09% of portfolio
225,000
Q1 2024 New
$13.8B
$12.9 Billion 1.07% of portfolio
100,000
Q1 2024 New
Praxis Precision Medicines Inc
-
$12.8 Billion 1.06% of portfolio
-
Q1 2024 New
$886M
$12.6 Billion 1.04% of portfolio
1,200,000
Q1 2024 Reduced 42.86%
$13.5B
$11.4 Billion 0.94% of portfolio
200,000
Q1 2024 New
$261M
$10.7 Billion 0.88% of portfolio
725,000
Q1 2024 New
$2.36B
$9.5 Billion 0.79% of portfolio
325,000
Q1 2024 New
$0
$8.14 Billion 0.67% of portfolio
25,000
Q1 2024 New
$4.71B
$8.01 Billion 0.66% of portfolio
45,000
Q1 2024 New
$290M
$7.77 Billion 0.64% of portfolio
655,000
Q1 2024 New
$1.6B
$7.26 Billion 0.6% of portfolio
2,200,000
Q1 2024 New
$2.42B
$6.96 Billion 0.58% of portfolio
100,000
Q1 2024 Added 66.67%
$7.48B
$6.91 Billion 0.57% of portfolio
100,000
Q1 2024 New
$323M
$6.56 Billion 0.54% of portfolio
695,000
Q1 2024 Reduced 32.2%
$4.07B
$6.15 Billion 0.51% of portfolio
75,000
Q1 2024 New
$335M
$6.03 Billion 0.5% of portfolio
1,350,000
Q1 2024 New
$43M
$6.08 Billion 0.5% of portfolio
4,500,000
Q1 2024 New
$318M
$5.87 Billion 0.49% of portfolio
800,000
Q1 2024 Reduced 37.98%
$306M
$5.59 Billion 0.46% of portfolio
600,000
Q1 2024 New
$85.8M
$5.58 Billion 0.46% of portfolio
1,200,000
Q1 2024 Added 943.48%
$6.73B
$5.19 Billion 0.43% of portfolio
15,000
Q1 2024 New
$2.88B
$5.14 Billion 0.42% of portfolio
110,000
Q1 2024 New
$8.91M
$4.98 Billion 0.41% of portfolio
800,000
Q1 2024 Reduced 73.33%
$1.63B
$4.19 Billion 0.35% of portfolio
130,000
Q4 2023 New
Alto Neuroscience Inc
-
$3.84 Billion 0.32% of portfolio
-
Q1 2024 New
Lexeo Therapeutics Inc
-
$2.74 Billion 0.23% of portfolio
-
Q1 2024 New
$492M
$2.52 Billion 0.21% of portfolio
360,000
Q1 2024 Added 1,672.88%

Summary

  • Portfolio
  • No. of Stocks 58
  • Current Value $1.21 Trillion
  • Prior Value $944 Billion
  • Filing
  • Period Q1 2024
  • Filing Date May 13, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 30 stocks
  • Additional Purchases 16 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 10 stocks
Track This Portfolio

Track Vestal Point Capital, LP Portfolio

Follow Vestal Point Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestal Point Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Vestal Point Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email